Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
The Molecular Point-of-Care Market Expected to Have a Bumpy Ride
The advent of the COVID-19 pandemic in 2020 has made the need for molecular point-of-care (mPOC) technologies, such as testing for strep throat, HPV, tuberculosis and more, have further driven demand from the clinical and medical sectors. As a result, more companies are offering related products to fulfill end-user demand. In January 2021, Kalorama Information […]
Danaher’s SCIEX and Molecular Devices Businesses Debut New Products
It has been a busy beginning of the year for Danaher’s Life Sciences segment. In January, the business reported 2020 revenues of $10.6 billion, representing 47% of the total revenues of science and technology conglomerate Danaher. The Life Sciences unit such as biopharmaceuticals and COVID-19 vaccines. In 2020, the pharmaceutical end-market represented approximately 25% of […]
Biden Administration Backs Science
Early signs from the Biden Administration indicate the Administration is elevating the role of science in its policymaking and actions. President Biden has already promoted the role of science advisor and director of the Office of Science and Technology policy to the level of a Cabinet position. Made up of 25 members, Cabinet members serve […]
Market Demand in the Single-Cell Genomics Sector Expected to Rise
The single-cell genomics discipline has become an essential component of biological research. These technologies are playing key roles in various scientific fields such as infectious disease treatments, cancer research and neurological studies. As a result, more companies are offering related products to fulfill end-user demand. In December 2020, Kalorama Information released its “ Single-Cell Genomics […]
SARS-CoV-2 Vaccines: Phase 1 vs. Phase 3
With US regulatory emergency use authorization (EUA) of two vaccines, a major threshold has been crossed in the response to COVID-19. According to the latest information, dated December 16, from the World Health Organization (WHO), more SARS-CoV-2 vaccine candidates are moving closer to completing the clinical trial phase. Twenty percent of the candidates in clinical […]